ISPOR Europe 2020

Improving Health: Establishing Incentives and Sharing Value

The live Virtual ISPOR Europe 2020 was held 16 – 19 November. We brought together a vibrant community of experts and thought leaders virtually to help shape the future of HEOR. Together, we looked at the fundamental conventions around value, risk, rewards, and the role of public and private sectors to drive innovation, investments and extending progress to broader public health concerns.

Slide presentations will be available (subject to speaker approval) at the ISPOR Presentation Database and on the Virtual ISPOR Europe 2020 Program page beginning 6 January, 2021.

Speakers

Agnes Saint-Raymond, MD

Head, International Affairs Division | European Medicines Agency (EMA), Amsterdam, The Netherlands

Andrew Briggs, DPhil

Professor of Health Economics Health Economics, Department of Health Services Research & Policy | London School of Hygiene & Tropical Medicine

Anja Schiel, PhD

Special Advisor, Lead Methodologist | Norwegian Medicines Agency, Oslo, Norway

Axel Mühlbacher, PhD, MBA

Professor for Health Economics and Health Care Management | Hochschule Neubrandenburg, Neubrandenburg, Germany

Bettina Ryll, MD, PhD

Founder, Past Chair of the Patient Advocates Working Group | Melanoma Patient Network Europe, European Society for Medical Oncology, Uppsala, Sweden

Eva Susanne Dietrich, MD

Professor | Institute for Evidence-Based Positioning in the Healthcare Sector, University of Bonn, Pharmaceutical Institute, Bonn, Germany

Fabio Pammolli

Full Professor, Department of Economics and Management | Politecnico di Milano, Milan, Italy

Ian Hudson, MD

Senior Advisor, Integrated Development | Bill and Melinda Gates Foundation, London, UK

Jack Scannell

Founder, Innogen Associate, Honorary Fellow | JW Scannell Analytics Ltd., School of Social and Political Science, University of Edinburgh, Edinburgh, United Kingdom

James Robins, MD

Mitchell L. and Robin LaFoley Dong Professor of Epidemiology | Harvard T.H. Chan School of Public Health, Boston, MA, USA

Lily (Huajie) Jin, PhD, MSc, MBBS

Senior Health Economist | Kings College London, London, UK

Maiwenn J Al, PhD

Associate Professor | Erasmus School of Health Policy & Management, Rotterdam, Netherlands

Mark Sculpher, PhD

Professor of Health Economics | Centre for Health Economics, University of York, York, UK

Mike Drummond, PhD

Professor of Health Economics, Centre for Health Economics | University of York, Heslington, York, England, UK

Nancy Dreyer, MPH, PhD

Senior Vice President, Chief Scientific Officer, Real-World Solutions | IQVIA, Cambridge, MA, USA

Natasha Azzopardi-Muscat, MD, PhD

Director of the Division of Country Health Policies and Systems | World Health Organization (WHO) Europe, Copenhagen, Denmark

Nathalie Bere, MPH

Patient Engagement | European Medicines Agency, The Netherlands

Nathalie Moll

Director General | European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Paola Testori Coggi

Special Advisor, Former Director General Health and Consumers | National Technological Cluster on Life Sciences (ALISEI), European Commission

Peter Marks, MD, PhD

Director, Center for Biologics Evaluation and Research (CBER) | U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA

Robert Golub, MD

Deputy Editor, Associate Professor of Medicine and Preventive Medicine | JAMA, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

Stephen Palmer, PhD

Professor | University of York, Centre for Health Economics, York, United Kingdom

Sylwia Bujkiewicz, PhD

Professor of Biostatistics | Biostatistics Research Group, Department of Health Sciences, University of Leicester, Leicester, United Kingdom

Uwe Siebert, MD, MPH, MSc, ScD

Professor | University for Health Sciences, Medical Informatics and Technology, Harvard Chan School of Public Health, Tirol, Austria

Xavier Kurz, MD, PhD, MSc

Head, Data Analytics Workstream | European Medicines Agency, Amsterdam, The Netherlands

Yann LeCam, MBA

Chief Executive Officer | European Organization for Rare Diseases (EURORDIS), Paris, France

Virtual ISPOR Europe 2020

#ISPOREurope

Improving Health: Establishing Incentives and Sharing Value

Speakers

Thank You to our Conference Key Supporters and Sponsors

Monday “Spotlight on Virtual ISPOR Europe 2020” Newsletter Sponsor

Tuesday “Spotlight on Virtual ISPOR Europe 2020” Newsletter Sponsor

Key Supporters

The Professional Society for
Health Economics and Outcomes Research